SHARE
Peptide Therapeutics - Global Market Outlook (2019-2027)

Peptide Therapeutics - Global Market Outlook (2019-2027)

4.2 (68 reviews)
Published: June 2020 ID: SMRC19307
4.2 (68 reviews)
Published: June 2020 ID: SMRC19307

1 Executive Summary       
         
2 Preface      
  
 2.1 Abstract       
 2.2 Stake Holders      
 2.3 Research Scope      
 2.4 Research Methodology     
  2.4.1 Data Mining     
  2.4.2 Data Analysis     
  2.4.3 Data Validation     
  2.4.4 Research Approach     
 2.5 Research Sources      
  2.5.1 Primary Research Sources    
  2.5.2 Secondary Research Sources    
  2.5.3 Assumptions     
         
3 Market Trend Analysis      
 3.1 Introduction       
 3.2 Drivers       
 3.3 Restraints      
 3.4 Opportunities      
 3.5 Threats       
 3.6 Technology Analysis     
 3.7 Application Analysis     
 3.8 End User Analysis      
 3.9 Emerging Markets      
 3.10 Impact of Covid-19      
          
4 Porters Five Force Analysis      
 4.1 Bargaining power of suppliers     
 4.2 Bargaining power of buyers     
 4.3 Threat of substitutes     
 4.4 Threat of new entrants     
 4.5 Competitive rivalry      
         
5 Global Peptide Therapeutics Market, By Type    
 5.1 Introduction      
 5.2 Innovative      
 5.3 Generic       
 5.4 Branded       
         
6 Global Peptide Therapeutics Market, By Type of Manufacturers  
 6.1 Introduction      
 6.2 Outsourced      
 6.3 In-house        
 6.4 Contract Manufacturing Organizations (CMOs)   
         
7 Global Peptide Therapeutics Market, By Route of Administration   

 7.1 Introduction      
 7.2 Pulmonary      
 7.3 Parenteral      
 7.4 Oral       
 7.5 Mucosal       
 7.6 Injection       
 7.7 Other Route of Administrations    
  7.7.1 Nasal      
  7.7.2 Intradermal     
         
8 Global Peptide Therapeutics Market, By Synthesis Technology  
 8.1 Introduction      
 8.2 Solid Phase Peptide Synthesis (SPPS)    
 8.3 Liquid Phase Peptide Synthesis (LPPS)    
 8.4 Hybrid Technology      
         
9 Global Peptide Therapeutics Market, By Type of Molecule   
 9.1 Introduction      
 9.2 Vasopressin      
 9.3 Somatostatin      
 9.4 Natriuretic      
 9.5 Luteinizing Hormone (LH)-Releasing Hormone (LHRH)  
 9.6 Insulins       
 9.7 Immunopeptide      
 9.8 Glucagon and Analogs     
 9.9 Calcitonin      
         
10 Global Peptide Therapeutics Market, By Application   
 10.1 Introduction      
 10.2 Cancer        
  10.2.1 Velcade (Bortezomib)    
  10.2.2 Zoladex (Goserelin)     
  10.2.3 Lupron/ Enantone/ Eligard (Leuprorelin)   
 10.3 Cardiovascular Disorder     
  10.3.1 Integrilin (Eptifibatide)    
  10.3.2 Angiomax (Bivalirudin)    
 10.4 Metabolic      
  10.4.1 Byetta (Exenatide)     
  10.4.2 Victoza (Liraglutide)    
 10.5 Respiratory      
 10.6 Gastro-Intestinal Infection (GIT)    
  10.6.1 Linzess (Linaclotide)    
  10.6.2 Gattex (Teduglutide)    
 10.7 Pain       
 10.8 Dermatology      
 10.9 Anti-infection      
 10.10 Central Nervous System     
  10.10.1 Copaxone (Glatiramer)    
 10.11 Renal       
 10.12 Infection       
  10.12.1 Victrelis (Boceprevir)    
  10.12.2 Incivek (Telaprevir)     
 10.13 Hematological Disorders     
  10.13.1 Kalbitor (Ecallantide)    
  10.13.2 Firazyr (Icatibant)     
 10.14 Acromegaly      
 10.15 Other Applications      
  10.15.1 Allergy/Immunological    
  10.15.2 Osteoporosis     
         
11 Global Peptide Therapeutics Market, By End User    
 11.1 Introduction      
 11.2 Pharmaceutical and Biotechnology Industries   
 11.3 Hospitals       
 11.4 Contract Research Organization    
 11.5 Academic and Research Institutes    
         
12 Global Peptide Therapeutics Market, By Geography   
 12.1 Introduction      
 12.2 North America      
  12.2.1 US      
  12.2.2 Canada      
  12.2.3 Mexico      
 12.3 Europe       
  12.3.1 Germany      
  12.3.2 UK      
  12.3.3 Italy      
  12.3.4 France      
  12.3.5 Spain      
  12.3.6 Rest of Europe     
 12.4 Asia Pacific      
  12.4.1 Japan      
  12.4.2 China      
  12.4.3 India      
  12.4.4 Australia      
  12.4.5 New Zealand     
  12.4.6 South Korea     
  12.4.7 Rest of Asia Pacific     
 12.5 South America      
  12.5.1 Argentina     
  12.5.2 Brazil      
  12.5.3 Chile      
  12.5.4 Rest of South America    
 12.6 Middle East & Africa     
  12.6.1 Saudi Arabia     
  12.6.2 UAE      
  12.6.3 Qatar      
  12.6.4 South Africa      
  12.6.5 Rest of Middle East & Africa    
         
 13 Key Developments       
 13.1 Agreements, Partnerships, Collaborations and Joint Ventures  
 13.2 Acquisitions & Mergers     
 13.3 New Product Launch     
 13.4 Expansions      
 13.5 Other Key Strategies     
         
14 Company Profiling       
 14.1 Teva Pharmaceutical     
 14.2 Bachem Holding AG      
 14.3 Sanofi       
 14.4 Pfizer Inc.      
 14.5 Amgen Inc.      
 14.6 Novartis AG      
 14.7 Lonza Inc.      
 14.8 GlaxoSmithKline (GSK)     
 14.9 Eli Lilly and Company     
 14.10 Bristol-Myers Squibb(BMS)     
 14.11 Merck & Co.      
 14.12 AstraZeneca PLC      
 14.13 Novo Nordisk A/S      
 14.14 Ipsen       
 14.15 Takeda Pharmaceutical Company Limited  


List of Tables        
1 Global Peptide Therapeutics Market Outlook, By Region (2018-2027) ($MN) 
2 Global Peptide Therapeutics Market Outlook, By Type (2018-2027) ($MN) 
3 Global Peptide Therapeutics Market Outlook, By Innovative (2018-2027) ($MN) 
4 Global Peptide Therapeutics Market Outlook, By Generic (2018-2027) ($MN) 
5 Global Peptide Therapeutics Market Outlook, By Branded (2018-2027) ($MN) 
6 Global Peptide Therapeutics Market Outlook, By Type of Manufacturers (2018-2027) ($MN)
7 Global Peptide Therapeutics Market Outlook, By Outsourced (2018-2027) ($MN) 
8 Global Peptide Therapeutics Market Outlook, By In-house (2018-2027) ($MN) 
9 Global Peptide Therapeutics Market Outlook, By Contract Manufacturing Organizations (CMOs) (2018-2027) ($MN)
10 Global Peptide Therapeutics Market Outlook, By Route of Administration (2018-2027) ($MN)
11 Global Peptide Therapeutics Market Outlook, By Pulmonary (2018-2027) ($MN) 
12 Global Peptide Therapeutics Market Outlook, By Parenteral (2018-2027) ($MN) 
13 Global Peptide Therapeutics Market Outlook, By Oral (2018-2027) ($MN)  
14 Global Peptide Therapeutics Market Outlook, By Mucosal (2018-2027) ($MN) 
15 Global Peptide Therapeutics Market Outlook, By Injection (2018-2027) ($MN) 
16 Global Peptide Therapeutics Market Outlook, By Other Route of Administrations (2018-2027) ($MN)
17 Global Peptide Therapeutics Market Outlook, By Nasal (2018-2027) ($MN) 
18 Global Peptide Therapeutics Market Outlook, By Intradermal (2018-2027) ($MN) 
19 Global Peptide Therapeutics Market Outlook, By Synthesis Technology (2018-2027) ($MN)
20 Global Peptide Therapeutics Market Outlook, By Solid Phase Peptide Synthesis (SPPS) (2018-2027) ($MN)
21 Global Peptide Therapeutics Market Outlook, By Liquid Phase Peptide Synthesis (LPPS) (2018-2027) ($MN)
22 Global Peptide Therapeutics Market Outlook, By Hybrid Technology (2018-2027) ($MN)
23 Global Peptide Therapeutics Market Outlook, By Type of Molecule (2018-2027) ($MN)
24 Global Peptide Therapeutics Market Outlook, By Vasopressin (2018-2027) ($MN) 
25 Global Peptide Therapeutics Market Outlook, By Somatostatin (2018-2027) ($MN) 
26 Global Peptide Therapeutics Market Outlook, By Natriuretic (2018-2027) ($MN) 
27 Global Peptide Therapeutics Market Outlook, By Luteinizing Hormone (LH)-Releasing Hormone (LHRH) (2018-2027) ($MN)
28 Global Peptide Therapeutics Market Outlook, By Insulins (2018-2027) ($MN) 
29 Global Peptide Therapeutics Market Outlook, By Immunopeptide (2018-2027) ($MN)
30 Global Peptide Therapeutics Market Outlook, By Glucagon and Analogs (2018-2027) ($MN)
31 Global Peptide Therapeutics Market Outlook, By Calcitonin (2018-2027) ($MN) 
32 Global Peptide Therapeutics Market Outlook, By Application (2018-2027) ($MN) 
33 Global Peptide Therapeutics Market Outlook, By Cancer (2018-2027) ($MN) 
34 Global Peptide Therapeutics Market Outlook, By Velcade (Bortezomib) (2018-2027) ($MN)
35 Global Peptide Therapeutics Market Outlook, By Zoladex (Goserelin) (2018-2027) ($MN)
36 Global Peptide Therapeutics Market Outlook, By Lupron/ Enantone/ Eligard (Leuprorelin) (2018-2027) ($MN)
37 Global Peptide Therapeutics Market Outlook, By Cardiovascular Disorder (2018-2027) ($MN)
38 Global Peptide Therapeutics Market Outlook, By Integrilin (Eptifibatide) (2018-2027) ($MN)
39 Global Peptide Therapeutics Market Outlook, By Angiomax (Bivalirudin) (2018-2027) ($MN)
40 Global Peptide Therapeutics Market Outlook, By Metabolic (2018-2027) ($MN) 
41 Global Peptide Therapeutics Market Outlook, By Byetta (Exenatide) (2018-2027) ($MN)
42 Global Peptide Therapeutics Market Outlook, By Victoza (Liraglutide) (2018-2027) ($MN)
43 Global Peptide Therapeutics Market Outlook, By Respiratory (2018-2027) ($MN) 
44 Global Peptide Therapeutics Market Outlook, By Gastro-Intestinal Infection (GIT) (2018-2027) ($MN)
45 Global Peptide Therapeutics Market Outlook, By Linzess (Linaclotide) (2018-2027) ($MN)
46 Global Peptide Therapeutics Market Outlook, By Gattex (Teduglutide) (2018-2027) ($MN)
47 Global Peptide Therapeutics Market Outlook, By Pain (2018-2027) ($MN)  
48 Global Peptide Therapeutics Market Outlook, By Dermatology (2018-2027) ($MN) 
49 Global Peptide Therapeutics Market Outlook, By Anti-infection (2018-2027) ($MN) 
50 Global Peptide Therapeutics Market Outlook, By Central Nervous System (2018-2027) ($MN)
51 Global Peptide Therapeutics Market Outlook, By Copaxone (Glatiramer) (2018-2027) ($MN)
52 Global Peptide Therapeutics Market Outlook, By Renal (2018-2027) ($MN) 
53 Global Peptide Therapeutics Market Outlook, By Infection (2018-2027) ($MN) 
54 Global Peptide Therapeutics Market Outlook, By Victrelis (Boceprevir) (2018-2027) ($MN)
55 Global Peptide Therapeutics Market Outlook, By Incivek (Telaprevir) (2018-2027) ($MN)
56 Global Peptide Therapeutics Market Outlook, By Hematological Disorders (2018-2027) ($MN)
57 Global Peptide Therapeutics Market Outlook, By Kalbitor (Ecallantide) (2018-2027) ($MN)
58 Global Peptide Therapeutics Market Outlook, By Firazyr (Icatibant) (2018-2027) ($MN)
59 Global Peptide Therapeutics Market Outlook, By Acromegaly (2018-2027) ($MN) 
60 Global Peptide Therapeutics Market Outlook, By Other Applications (2018-2027) ($MN)
61 Global Peptide Therapeutics Market Outlook, By Allergy/Immunological (2018-2027) ($MN)
62 Global Peptide Therapeutics Market Outlook, By Osteoporosis (2018-2027) ($MN) 
63 Global Peptide Therapeutics Market Outlook, By End User (2018-2027) ($MN) 
64 Global Peptide Therapeutics Market Outlook, By Pharmaceutical and Biotechnology Industries (2018-2027) ($MN)
65 Global Peptide Therapeutics Market Outlook, By Hospitals (2018-2027) ($MN) 
66 Global Peptide Therapeutics Market Outlook, By Contract Research Organization (2018-2027) ($MN)
67 Global Peptide Therapeutics Market Outlook, By Academic and Research Institutes (2018-2027) ($MN)
         
Note:
Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

Select License Type

Single User License (PDF)
2 - 5 User License (PDF)
Site License (PDF)
Corporate License (PDF)

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials